Euronews: Trump administration pulls Covid-19 vaccine safety studies
The US FDA has halted the publication of a number of scientific studies confirming vaccine safety.
ESWI Activity Report for 2025
Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings
Immunomodulation could represent a rational therapeutic approach to be evaluated in selected patients.
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
In two open-label trials, nirmatrelvir–ritonavir did not reduce the incidence of hospitalization or death among vaccinated higher-risk participants with SARS-CoV-2 infection.
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections
AAN-I-IFNs+ patients with life-threatening COVID-19 pneumonia harbor circulating type-I IFN-specific B cells indistinguishable from patients bearing T cell tolerance defects of genetic origin.
Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia
New insights into the diversity of SC2r-CoVs dynamically co-circulating in Southeast Asia as well as the virological characteristics of these viruses relative to SARS-CoV-2.
Health Worker Influenza Vaccination Programs: A Key to Pandemic Preparedness and Effective COVID-19 Vaccine Deployment in Low- and Middle-Income Countries
Countries with established seasonal influenza vaccination programs were significantly better prepared to deploy COVID-19 vaccines.
News
Policy & Recommendations
Europe strengthens lab defences against key pathogens
ESWI Chair Colin Russell was featured in a Medscape article on the EU reference laboratories aiming to improve disease surveillance data, including respiratory viruses.
